MARK CHUA: Open Payments
NPI 1659819563 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 36 payments from 10 companies in 2025. Trend: 2023 $3,801 · 2024 $1,517 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $561 |
| Novo Nordisk Inc | 4 | $281 |
| Axsome Therapeutics, Inc. | 8 | $168 |
| Phathom Pharmaceuticals, Inc. | 1 | $132 |
| PFIZER INC. | 3 | $62 |
| Lilly USA, LLC | 2 | $41 |
| Exact Sciences Corporation | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Amgen Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: AIRSUPRA, Ozempic, BREZTRI, Auvelity, VOQUEZNA, FARXIGA, NURTEC ODT, Wegovy.
Industry payments across GA — which companies pay providers there.
